Entero Therapeutics Inc (ENTO)
2.74
+0.11
(+4.18%)
USD |
NASDAQ |
May 31, 16:00
2.75
+0.01
(+0.36%)
Pre-Market: 20:00
Entero Therapeutics Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2020 | 0.0368M |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | |
| September 30, 2017 | 0.1736M |
| June 30, 2017 | 0.16M |
| March 31, 2017 | 0.2399M |
| December 31, 2016 | 0.2027M |
| September 30, 2016 | 0.2505M |
| June 30, 2016 | 0.3416M |
| March 31, 2016 | 1.084M |
| December 31, 2015 | 1.075M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.0368M
Minimum
Jun 2020
0.0368M
Maximum
Jun 2020
0.0368M
Average
0.0368M
Median
Jun 2020
Accounts Receivable (Quarterly) Benchmarks
| BioVie Inc | -- |
| Jaguar Health Inc | 1.512M |
| Benitec Biopharma Inc | 0.053M |
| Immuneering Corp | -- |
| NovaBay Pharmaceuticals Inc | 0.734M |